A study to see if it is safe to give a new asthma reliever drug (called vilanterol) to 5 to 11 year old children with asthma - Trial 2012-000741-12
Access comprehensive clinical trial information for 2012-000741-12 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2012-000741-12
Trial Details
EU Clinical Trials Register • 2012-000741-12
A study to see if it is safe to give a new asthma reliever drug (called vilanterol) to 5 to 11 year old children with asthma
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development Ltd
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Subjects currently receiving (or have received within 4 weeks of screening) any of
ICD-10 Classifications
Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Predominantly allergic asthma
Data Source
EU Clinical Trials Register
2012-000741-12
Non-Device Trial